Physician profile
Eve E Barna
NPI 1174089627
$777.00
in general payments reported to CMS, 2019-2025
18 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $21.23 · 2024: $379 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $125.07 | 2024-2025 | |
| Abbvie INC. | $119.79 | 2023-2025 | |
| Amgen INC. | $74.66 | 2024-2025 | Otezla, Krystexxa, Repatha |
| Inspire Medical Systems, INC. | $62.94 | 2025 | Inspire |
| Lilly USA, LLC | $53.79 | 2024-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $49.99 | 2024-2025 | Ozempic, Rybelsus, Tresiba |
| Glaxosmithkline, LLC. | $49.81 | 2025 | Arexvy, Shingrix |
| Lundbeck LLC | $48.01 | 2024 | Vyepti |
| Edwards Lifesciences Corporation | $32.74 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $32.28 | 2024-2025 | Intellis Adaptivestim |
| Abiomed | $20.73 | 2024 | Impella |
| Eisai INC. | $17.20 | 2025 | |
| Merck Sharp & Dohme LLC | $16.98 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Tris Pharma INC | $16.24 | 2024 | Dyanavel Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.17 | 2025 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.01 | 2025 | Farxiga |
| Ibsa Pharma INC. | $13.91 | 2024 | Flector, Licart, Tirosint |
| Organon LLC | $13.68 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eve Barna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.